Small-Molecule Inhibitors of Signal Transducer and Activator of Transcription 3 Protect Against Angiotensin II–Induced Vascular Dysfunction and Hypertension

No abstract is available for this paper.

• Publication year

  2013

• Venue

  HYPERTENSION

• Publication date

  2013-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/HYPERTENSIONAHA.111.00299PMID 23266544PMCID PMC3589547
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hypertension and longitudinal changes in cerebral blood flow: The SMART‐MR study

  2012cited by this paper
• The interleukin-6 pathway and atherosclerosis.

  2012cited by this paper
• Jak2-Independent Activation of Stat3 by Intracellular Angiotensin II in Human Mesangial Cells

  2011cited by this paper
• The cerebrovascular dysfunction induced by slow pressor doses of angiotensin II precedes the development of hypertension.

  2011cited by this paper
• Protecting against vascular disease in brain.

  2011influential reference
• Elevated Maternal Soluble Gp130 and IL-6 Levels and Reduced Gp130 and SOCS-3 Expressions in Women Complicated With Preeclampsia

  2011cited by this paper
• Endothelial Function in Resistance and Conduit Arteries and 5-Year Risk of Cardiovascular Disease

  2011cited by this paper
• Angiotensin II utilizes Janus kinase 2 in hypertension, but not in the physiological control of blood pressure, during low-salt intake.

  2011cited by this paper
• Carotid Intimal Medial Thickness Predicts Cognitive Decline Among Adults Without Clinical Vascular Disease

  2009cited by this paper
• Endogenous Interleukin-10 Inhibits Angiotensin II–Induced Vascular Dysfunction

  2009influential reference
• Stat3 promotes directional cell migration by regulating Rac1 activity via its activator βPIX

  2009cited by this paper
• Role of oxidative stress and AT1 receptors in cerebral vascular dysfunction with aging.

  2009influential reference
• The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-β signaling

  2009cited by this paper
• Endothelium-Specific Interference With Peroxisome Proliferator Activated Receptor Gamma Causes Cerebral Vascular Dysfunction in Response to a High-Fat Diet

  2008cited by this paper
• Losartan improves impaired nitric oxide synthase-dependent dilatation of cerebral arterioles in type 1 diabetic rats.

  2008cited by this paper
• Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity

  2007cited by this paper
• Angiotensin II induces IL-6 expression and the Jak-STAT3 pathway in aortic adventitia of LDL receptor-deficient mice.

  2007cited by this paper
• IL-6 Deficiency Protects Against Angiotensin II–Induced Endothelial Dysfunction and Hypertrophy

  2007influential reference
• Prediction of Clinical Cardiovascular Events With Carotid Intima-Media Thickness: A Systematic Review and Meta-Analysis

  2007cited by this paper
• Angiotensin II Attenuates Endothelium-Dependent Responses in the Cerebral Microcirculation Through Nox-2–Derived Radicals

  2006cited by this paper
• Stattic: a small-molecule inhibitor of STAT3 activation and dimerization.

  2006cited by this paper
• Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney

  2006cited by this paper
• Critical Role for CuZn-Superoxide Dismutase in Preventing Angiotensin II-Induced Endothelial Dysfunction

  2005influential reference
• Overexpression of CuZn-SOD Prevents Lipopolysaccharide-Induced Endothelial Dysfunction

  2004influential reference
• Hypercholesterolemia Stimulates Angiotensin Peptide Synthesis and Contributes to Atherosclerosis Through the AT1A Receptor

  2004cited by this paper
• Angiotensin II–Induced Vascular Dysfunction Is Mediated by the AT1A Receptor in Mice

  2004influential reference
• Role of oxidative stress in angiotensin-induced hypertension.

  2003cited by this paper
• Gene-Targeted Mice Reveal a Critical Role for Inducible Nitric Oxide Synthase in Vascular Dysfunction During Diabetes

  2003cited by this paper
• Signalling: STATs: transcriptional control and biological impact

  2002cited by this paper
• Vascular inflammation and the renin-angiotensin system.

  2002cited by this paper
• Activation of JAK2 by the oxidative stress generated with oxidized low-density lipoprotein.

  2001cited by this paper
• Functional cross-talk between the cyclic AMP and Jak/STAT signaling pathways in vascular smooth muscle cells

  2000cited by this paper
• Janus kinases: components of multiple signaling pathways

  2000cited by this paper
• cSrc is a major cytosolic tyrosine kinase in vascular tissue.

  1999cited by this paper
• Autoregulation of the Stat3 Gene through Cooperation with a cAMP-responsive Element-binding Protein*

  1998cited by this paper
• Responses of carotid artery in mice deficient in expression of the gene for endothelial NO synthase.

  1998cited by this paper
• Responses of carotid artery in mice deficient in expression of the gene for endothelial NO synthase.

  1998cited by this paper
• TGF-beta signal transduction.

  1998cited by this paper
• IL‐10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3‐dependent and ‐independent pathways

  1998influential reference
• Inhibition of Cdk2 activation by selected tyrphostins causes cell cycle arrest at late G1 and S phase.

  1998cited by this paper
• Dependence on the Motif YIPP for the Physical Association of Jak2 Kinase with the Intracellular Carboxyl Tail of the Angiotensin II AT1 Receptor*

  1997cited by this paper
• Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality.

  1997cited by this paper
• Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor

  1995influential reference
• Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1

  1991cited by this paper
• Tyrphostins--potential antiproliferative agents and novel molecular tools.

  1990cited by this paper
• Hypertension

  1931cited by this paper

• Post-translational modifications of Stat3: The state of the art.

  2025cites this paper
• STAT protein family and cardiovascular diseases: overview of pathological mechanisms and therapeutic implications

  2024cites this paper
• Proliferation, migration and phenotypic transformation of VSMC induced via Hcy related to up-expression of WWP2 and p-STAT3

  2024cites this paper
• SENP1 Protects Against Pressure Overload‐Induced Cardiac Remodeling and Dysfunction Via Inhibiting STAT3 Signaling

  2022cites this paper
• COX/iNOS dependence for angiotensin-II-induced endothelial dysfunction.

  2022cites this paper
• Angiotensin II‐induced endothelial dysfunction: Impact of sex, genetic background, and rho kinase

  2022cites this paper
• Theories and Molecular Basis of Vascular Aging: A Review of the Literature from VascAgeNet Group on Pathophysiological Mechanisms of Vascular Aging

  2022influential citation
• Neuronal STAT3/HIF-1α/PTRF axis-mediated bioenergetic disturbance exacerbates cerebral ischemia-reperfusion injury via PLA2G4A

  2022cites this paper
• Endothelium function biomarkers and carotid intima-media thickness changes in relation to NOS3 (rs2070744) and GNB3 (rs5443) genes polymorphism in the essential arterial hypertension

  2022cites this paper
• Exploiting the STAT3 Nexus in Cancer-Associated Fibroblasts to Improve Cancer Therapy

  2021cites this paper
• STAT3 inhibitor mitigates cerebral amyloid angiopathy and parenchymal amyloid plaques while improving cognitive functions and brain networks

  2021cites this paper
• Hydrogen sulfide prevents arterial medial calcification in rats with diabetic nephropathy

  2021cites this paper
• Silencing IL12p35 Promotes Angiotensin II-Mediated Abdominal Aortic Aneurysm through Activating the STAT4 Pathway

  2021cites this paper
• Activation of the Central Renin-Angiotensin System Causes Local Cerebrovascular Dysfunction

  2021cites this paper
• Reduction of serum-induced endothelial STAT3(Y705) activation is associated with preeclampsia.

  2021cites this paper
• UPLC-MS-Based Serum Metabolomics Reveals Potential Biomarkers of Ang II-Induced Hypertension in Mice

  2021cites this paper
• Circulating miR-155 and JAK2/STAT3 Axis in Acute Ischemic Stroke Patients and Its Relation to Post-Ischemic Inflammation and Associated Ischemic Stroke Risk Factors

  2021cites this paper
• Diabetes and hypertension: Pivotal involvement of purinergic signaling

  2021cites this paper
• WWP2 regulates SIRT1‐STAT3 acetylation and phosphorylation involved in hypertensive angiopathy

  2020cites this paper
• P-STAT3 Inhibition Activates Endoplasmic Reticulum Stress-Induced Splenocyte Apoptosis in Chronic Stress

  2020cites this paper
• Vasculo-Neuronal Coupling and Neurovascular Coupling at the Neurovascular Unit: Impact of Hypertension

  2020cites this paper
• Interleukin-9 Deletion Relieves Vascular Dysfunction and Decreases Blood Pressure via the STAT3 Pathway in Angiotensin II-Treated Mice

  2020cites this paper
• Hydrogen Sulfide Prevents Elastin Loss and Attenuates Calcification Induced by High Glucose in Smooth Muscle Cells through Suppression of Stat3/Cathepsin S Signaling Pathway

  2019cites this paper
• Targeted inhibition of STAT3 as a potential treatment strategy for atherosclerosis

  2019cites this paper
• Hypertension, dietary salt and cognitive impairment

  2018cites this paper
• Genome-Wide Inhibition of Pro-atherogenic Gene Expression by Multi-STAT Targeting Compounds as a Novel Treatment Strategy of CVDs

  2018cites this paper
• YAP via interacting with STAT3 regulates VEGF‐induced angiogenesis in human retinal microvascular endothelial cells

  2018cites this paper
• Angiotensin II Attenuates the Bioactivities of Human Endothelial Progenitor Cells via Downregulation of β2-Adrenergic Receptor

  2018cites this paper
• A novel small molecular STAT3 inhibitor, 5Br-6b, induces apoptosis and inhibits migration in colorectal cancer cells

  2018cites this paper
• Hypertension and increased endothelial mechanical stretch promote monocyte differentiation and activation: roles of STAT3, interleukin 6 and hydrogen peroxide

  2018cites this paper
• Mineralocorticoid receptor antagonism improves parenchymal arteriole dilation via a TRPV4-dependent mechanism and prevents cognitive dysfunction in hypertension.

  2018cites this paper
• An Unexpected Journey: A Medicinal Chemistry Exploration through the Realm of Protein Tyrosine Phosphatases, Signal Transducers, and Receptor Tyrosine Kinases

  2017cites this paper
• Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke

  2017cites this paper
• Genetic Interference With Endothelial PPAR-&ggr; (Peroxisome Proliferator–Activated Receptor-&ggr;) Augments Effects of Angiotensin II While Impairing Responses to Angiotensin 1–7

  2017cites this paper
• Cellular and Oxidative Mechanisms Associated with Interleukin-6 Signaling in the Vasculature

  2017influential citation
• Reactive Oxygen Species and the Regulation of Cerebral Vascular Tone

  2017cites this paper
• Interleukin 22 Promotes Blood Pressure Elevation and Endothelial Dysfunction in Angiotensin II–Treated Mice

  2017cites this paper
• Genetic Interference With Endothelial Peroxisome Proliferator – Activated Receptor-γ Augments Effects of Angiotensin II While Impairing Responses to Angiotensin 1 – 7

  2017cites this paper
• STAT1 and IRF8 in Vascular Inflammation and Cardiovascular Disease: Diagnostic and Therapeutic Potential

  2016cites this paper
• Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular disease

  2016cites this paper
• Perivascular macrophages mediate the neurovascular and cognitive dysfunction associated with hypertension.

  2016cites this paper
• IL-6/STAT3 signaling in mice with dysfunctional type-2 ryanodine receptor

  2016cites this paper
• Senescent endothelial cells: Potential modulators of immunosenescence and ageing.

  2016cites this paper
• Context-dependent effects of SOCS3 in angiotensin II-induced vascular dysfunction and hypertension in mice: mechanisms and role of bone marrow-derived cells.

  2016influential citation
• Off-Target Vascular Effects of Cholesteryl Ester Transfer Protein Inhibitors Involve Redox-Sensitive and Signal Transducer and Activator of Transcription 3–Dependent Pathways

  2016cites this paper
• Endothelium, the Blood–Brain Barrier, and Hypertension

  2016cites this paper
• Ginkgolide A reduces inflammatory response in high-glucose-stimulated human umbilical vein endothelial cells through STAT3-mediated pathway.

  2015cites this paper
• Genetic Interference With Peroxisome Proliferator–Activated Receptor &ggr; in Smooth Muscle Enhances Myogenic Tone in the Cerebrovasculature via A Rho Kinase–Dependent Mechanism

  2015cites this paper
• Emerging translational approaches to target STAT3 signalling and its impact on vascular disease

  2015cites this paper
• Angiotensin II-induced endothelial dysfunction is temporally linked with increases in interleukin-6 and vascular macrophage accumulation

  2014cites this paper
• Mechanisms of vascular disease: divergent roles for suppressor of cytokine signaling 3 in angiotensin II-induced vascular dysfunction

  2014influential citation
• Endothelial dysfunction and hypertension.

  2014influential citation
• Treating Heart Failure with Preserved Ejection Fraction Related to Arterial Stiffness. Can we Kill Two Birds With One Stone?

  2014cites this paper
• Effekte von Ciliary Neurotrophic Factor (CNTF) auf Angiotensin II-induzierte Hypertonie

  2014cites this paper
• Interleukin-10 protects against aging-induced endothelial dysfunction

  2013cites this paper
• Heart Failure with Preserved Ejection Fraction: Emerging Drug Strategies

  2013cites this paper
• Protective role of IL-6 in vascular remodeling in Schistosoma pulmonary hypertension.

  2013cites this paper
• TIMP3 is the primary TIMP to regulate agonist-induced vascular remodelling and hypertension.

  2013cites this paper
• Protective effects of losartan in mice with chronic viral myocarditis induced by coxsackievirus B3.

  2013cites this paper
• Brandes Endothelial Dysfunction and Hypertension

  year unknowncites this paper